| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advisory Board and Contents
|
|
|
|
|
11 |
p. i
|
artikel
|
| 2 |
Advisory Board and Contents
|
|
|
|
|
11 |
p. i
|
artikel
|
| 3 |
Advisory Board and Contents
|
|
|
|
|
11 |
p. i
|
artikel
|
| 4 |
Advisory Board and Contents
|
|
|
|
|
11 |
p. i-ii
|
artikel
|
| 5 |
Age-associated differences in the cancer molecular landscape
|
Chatsirisupachai, Kasit
|
|
|
|
11 |
p. 962-971
|
artikel
|
| 6 |
A novel transcriptomic-based classifier for senescent cancer cells
|
Varughese, Feba Mariam
|
|
|
|
11 |
p. 971-973
|
artikel
|
| 7 |
Anxiolytics cause anxiety in pancreatic cancer
|
Chen, Yang
|
|
|
|
11 |
p. 874-875
|
artikel
|
| 8 |
BAP1 Missense Mutations in Cancer: Friend or Foe?
|
Okonska, Agata
|
|
2019
|
|
11 |
p. 659-662
|
artikel
|
| 9 |
Basal S-Nitrosylation Is the Guardian of Tissue Homeostasis
|
Furuta, Saori
|
|
2017
|
|
11 |
p. 744-748
|
artikel
|
| 10 |
Battle of the γδ T cell subsets in the gut
|
Mensurado, Sofia
|
|
|
|
11 |
p. 881-883
|
artikel
|
| 11 |
Better together: circulating tumor cell clustering in metastatic cancer
|
Schuster, Emma
|
|
|
|
11 |
p. 1020-1032
|
artikel
|
| 12 |
Beyond matrix stiffness: targeting force-induced cancer drug resistance
|
Kalli, Maria
|
|
|
|
11 |
p. 937-954
|
artikel
|
| 13 |
Breast Cancer: Multiple Subtypes within a Tumor?
|
Yeo, Syn Kok
|
|
2017
|
|
11 |
p. 753-760
|
artikel
|
| 14 |
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer
|
Pereira, Brooke A.
|
|
2019
|
|
11 |
p. 724-741
|
artikel
|
| 15 |
Cancer and RASSF1A/RASSF1C, the Two Faces of Janus
|
Dubois, Fatéméh
|
|
2019
|
|
11 |
p. 662-665
|
artikel
|
| 16 |
Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas
|
Drees, Esther E.E.
|
|
|
|
11 |
p. 910-923
|
artikel
|
| 17 |
Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis
|
Bullard, Whitney L.
|
|
2018
|
|
11 |
p. 729-740
|
artikel
|
| 18 |
Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity
|
Salvagno, Camilla
|
|
|
|
11 |
p. 930-943
|
artikel
|
| 19 |
DNA Damage Repair Deficiency in Prostate Cancer
|
Burdak-Rothkamm, Susanne
|
|
|
|
11 |
p. 974-984
|
artikel
|
| 20 |
Doubling Down on BRCA-Mutated Cancer
|
Wahner Hendrickson, Andrea E.
|
|
2017
|
|
11 |
p. 743-744
|
artikel
|
| 21 |
Drug independence and the curability of cancer by combination chemotherapy
|
Pomeroy, Amy E.
|
|
|
|
11 |
p. 915-929
|
artikel
|
| 22 |
Editorial Board and Contents
|
|
|
2017
|
|
11 |
p. i
|
artikel
|
| 23 |
Editorial Board and Contents
|
|
|
2016
|
|
11 |
p. i
|
artikel
|
| 24 |
Editorial Board and Contents
|
|
|
2018
|
|
11 |
p. i
|
artikel
|
| 25 |
Editorial Board and Contents
|
|
|
2019
|
|
11 |
p. i-ii
|
artikel
|
| 26 |
Emerging Roles for Eosinophils in the Tumor Microenvironment
|
Reichman, Hadar
|
|
2016
|
|
11 |
p. 664-675
|
artikel
|
| 27 |
Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics
|
Zhang, Xiaonan
|
|
2016
|
|
11 |
p. 657-663
|
artikel
|
| 28 |
Extracellular vesicle lipids in cancer immunoevasion
|
Chen, Siyu
|
|
|
|
11 |
p. 883-886
|
artikel
|
| 29 |
FBXW10: a male-biased E3 ligase in liver cancer
|
Sahay, Osheen
|
|
|
|
11 |
p. 876-878
|
artikel
|
| 30 |
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment
|
De Jaeghere, Emiel A.
|
|
2019
|
|
11 |
p. 704-723
|
artikel
|
| 31 |
β-Galactosylceramidase in cancer: friend or foe?
|
Presta, Marco
|
|
|
|
11 |
p. 974-977
|
artikel
|
| 32 |
Glioblastoma revisited: from neuronal-like invasion to pacemaking
|
Heuer, Sophie
|
|
|
|
11 |
p. 887-896
|
artikel
|
| 33 |
Glypicans as Cancer Therapeutic Targets
|
Li, Nan
|
|
2018
|
|
11 |
p. 741-754
|
artikel
|
| 34 |
GOT2 consider the tumor microenvironment
|
Do, Brian T.
|
|
|
|
11 |
p. 884-886
|
artikel
|
| 35 |
Harnessing Real-World Evidence for the Development of Novel Cancer Therapies
|
Greshock, Joel
|
|
|
|
11 |
p. 907-909
|
artikel
|
| 36 |
Harnessing the Microbiome for Pancreatic Cancer Immunotherapy
|
Vitiello, Gerardo A.
|
|
2019
|
|
11 |
p. 670-676
|
artikel
|
| 37 |
Immune Priming of the Tumor Microenvironment by Radiation
|
Jiang, Wen
|
|
2016
|
|
11 |
p. 638-645
|
artikel
|
| 38 |
Immune vulnerabilities of mutant KRAS in pancreatic cancer
|
Cheng, Noah C.
|
|
|
|
11 |
p. 928-936
|
artikel
|
| 39 |
Immunity beyond cancer cells: perspective from tumor tissue
|
Gao, Shengyu
|
|
|
|
11 |
p. 1010-1019
|
artikel
|
| 40 |
Immunity Gone Astray – NETs in Cancer
|
Cedervall, Jessica
|
|
2016
|
|
11 |
p. 633-634
|
artikel
|
| 41 |
Inflammation: the incubator of the tumor microenvironment
|
Denk, Dominic
|
|
|
|
11 |
p. 901-914
|
artikel
|
| 42 |
Interferon signaling restrains renal cell carcinoma heterogeneity
|
Holicek, Peter
|
|
|
|
11 |
p. 871-873
|
artikel
|
| 43 |
Leveraging circulating microbial DNA for early cancer detection
|
Kataria, Radhika
|
|
|
|
11 |
p. 879-882
|
artikel
|
| 44 |
Lipid Metabolism at the Nexus of Diet and Tumor Microenvironment
|
Peck, Barrie
|
|
2019
|
|
11 |
p. 693-703
|
artikel
|
| 45 |
Lysophosphatidate Signaling: The Tumor Microenvironment’s New Nemesis
|
Benesch, Matthew G.K.
|
|
2017
|
|
11 |
p. 748-752
|
artikel
|
| 46 |
Metabolic Stress Triggers Immune Escape by Tumors
|
Nunes, Joana B.
|
|
2019
|
|
11 |
p. 656-658
|
artikel
|
| 47 |
Migrating into the Tumor: a Roadmap for T Cells
|
van der Woude, Lieke L.
|
|
2017
|
|
11 |
p. 797-808
|
artikel
|
| 48 |
miRNA–Microbiota Interaction in Gut Homeostasis and Colorectal Cancer
|
Dong, Jiayi
|
|
2019
|
|
11 |
p. 666-669
|
artikel
|
| 49 |
Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis
|
Zacksenhaus, Eldad
|
|
2017
|
|
11 |
p. 768-779
|
artikel
|
| 50 |
Modulating Treg stability to improve cancer immunotherapy
|
Kang, Jee Hye
|
|
|
|
11 |
p. 911-927
|
artikel
|
| 51 |
mTOR Signaling Confers Resistance to Targeted Cancer Drugs
|
Guri, Yakir
|
|
2016
|
|
11 |
p. 688-697
|
artikel
|
| 52 |
New Opportunities and Challenges to Defeat Cancer Stem Cells
|
Ramos, Erika K.
|
|
2017
|
|
11 |
p. 780-796
|
artikel
|
| 53 |
Next batter up! Targeting cancers with KRAS-G12D mutations
|
Zeissig, Mara N.
|
|
|
|
11 |
p. 955-967
|
artikel
|
| 54 |
NFκB and MHC-1 Interplay in Neuroblastoma and Immunotherapy
|
Spel, Lotte
|
|
2018
|
|
11 |
p. 715-717
|
artikel
|
| 55 |
Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes
|
Taeubner, Julia
|
|
2018
|
|
11 |
p. 718-728
|
artikel
|
| 56 |
Perivascular niches: critical hubs in cancer evolution
|
Nowosad, Ada
|
|
|
|
11 |
p. 897-910
|
artikel
|
| 57 |
Plasticity and Clonality of Cancer Cell States
|
Barkley, Dalia
|
|
2019
|
|
11 |
p. 655-656
|
artikel
|
| 58 |
Precision sampling fuels precision oncology: an evolutionary perspective
|
Manini, Claudia
|
|
|
|
11 |
p. 978-981
|
artikel
|
| 59 |
Prostate Luminal Progenitor Cells in Development and Cancer
|
Zhang, Dingxiao
|
|
2018
|
|
11 |
p. 769-783
|
artikel
|
| 60 |
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
|
Pouget, Jean-Pierre
|
|
|
|
11 |
p. 968-981
|
artikel
|
| 61 |
Receptor Tyrosine Kinase Fusions as an Actionable Resistance Mechanism to EGFR TKIs in EGFR-Mutant Non-Small-Cell Lung Cancer
|
Zhu, Viola W.
|
|
2019
|
|
11 |
p. 677-692
|
artikel
|
| 62 |
Retinoblastoma Binding Protein 6, Another p53 Monitor
|
Ntwasa, Monde
|
|
2016
|
|
11 |
p. 635-637
|
artikel
|
| 63 |
Revisiting the concept of childhood preleukemia
|
Cobaleda, Cesar
|
|
|
|
11 |
p. 887-889
|
artikel
|
| 64 |
SASP: Tumor Suppressor or Promoter? Yes!
|
Rao, Sonia G.
|
|
2016
|
|
11 |
p. 676-687
|
artikel
|
| 65 |
Serrated Colorectal Cancer: The Road Less Travelled?
|
Nakanishi, Yuki
|
|
2019
|
|
11 |
p. 742-754
|
artikel
|
| 66 |
Solving the puzzle of what makes immunotherapies work
|
Ma, Xiaoxiao
|
|
|
|
11 |
p. 890-900
|
artikel
|
| 67 |
Subscription and Copyright Information
|
|
|
2019
|
|
11 |
p. e1
|
artikel
|
| 68 |
Subscription & copyright page
|
|
|
|
|
11 |
p. e1
|
artikel
|
| 69 |
Subscription & copyright page
|
|
|
|
|
11 |
p. e1
|
artikel
|
| 70 |
Subscription & copyright page
|
|
|
|
|
11 |
p. e1
|
artikel
|
| 71 |
Subscription & copyright page
|
|
|
|
|
11 |
p. e1
|
artikel
|
| 72 |
Supramolecular Assemblies for Macrophage Activation in Cancer Therapy
|
Mejia, Franklin
|
|
2018
|
|
11 |
p. 713-714
|
artikel
|
| 73 |
Synthetically Lethal Interactions of ATM, ATR, and DNA-PKcs
|
Kantidze, Omar L.
|
|
2018
|
|
11 |
p. 755-768
|
artikel
|
| 74 |
Targeting EMT in Cancer with Repurposed Metabolic Inhibitors
|
Ramesh, Vignesh
|
|
|
|
11 |
p. 942-950
|
artikel
|
| 75 |
Technical and biological constraints on ctDNA-based genotyping
|
Herberts, Cameron
|
|
|
|
11 |
p. 995-1009
|
artikel
|
| 76 |
The Glycogen Shunt Maintains Glycolytic Homeostasis and the Warburg Effect in Cancer
|
Shulman, Robert G.
|
|
2017
|
|
11 |
p. 761-767
|
artikel
|
| 77 |
The ‘Pushmi-Pullyu’ of DNA REPAIR: Clinical Synthetic Lethality
|
Ivy, S. Percy
|
|
2016
|
|
11 |
p. 646-656
|
artikel
|
| 78 |
Therapeutic targeting of regulatory T cells in cancer
|
Shan, Feng
|
|
|
|
11 |
p. 944-961
|
artikel
|
| 79 |
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
|
Böttcher, Jan P.
|
|
2018
|
|
11 |
p. 784-792
|
artikel
|
| 80 |
Tilting MYC toward cancer cell death
|
Harrington, Colleen T.
|
|
|
|
11 |
p. 982-994
|
artikel
|
| 81 |
Tumor Excision as a Metastatic Russian Roulette: Perioperative Interventions to Improve Long-Term Survival of Cancer Patients
|
Ben-Eliyahu, Shamgar
|
|
|
|
11 |
p. 951-959
|
artikel
|
| 82 |
Tumour microenvironment 3D-modelling: simplicity to complexity and back again
|
Carter, Edward P.
|
|
|
|
11 |
p. 1033-1046
|
artikel
|
| 83 |
Unfolded Protein Response in Leukemia: From Basic Understanding to Therapeutic Opportunities
|
Khateb, Ali
|
|
|
|
11 |
p. 960-973
|
artikel
|
| 84 |
Why Great Mitotic Inhibitors Make Poor Cancer Drugs
|
Yan, Victoria C.
|
|
|
|
11 |
p. 924-941
|
artikel
|
Tijdschrift beschrijving